维生素K:重症疾病中潜在的缺失环节——范围综述
该范围综述按PRISMA-ScR指南检索PubMed、Embase和Cochrane数据库(截至2023年12月),纳入13项关于成人ICU患者维生素K缺乏和/或补充的研究。观察性研究显示ICU患者PIVKA-II水平较高,提示维生素K状态降低;缺乏与营养不良、吸收受损、抗生素使用、周转增加和遗传因素有关。补充研究提示维生素K可改善状态但不能完全正常化。维生素K缺乏可能与ICU停留延长、机械通气和死亡率增加相关。作者认为解决ICU患者维生素K缺乏对减轻重症风险至关重要,但最佳管理策略需进一步研究。
要点
- ICU患者维生素K缺乏与营养不良、吸收受损、抗生素使用、周转增加和遗传因素相关。
- 观察性研究显示ICU患者PIVKA-II水平较高,提示维生素K状态降低。
- 补充研究提示维生素K可改善状态但不能完全正常化。
- 维生素K缺乏可能与ICU停留延长、机械通气和死亡率增加相关。
- 遗传多态性和微生物组紊乱也促进缺乏,强调个体化营养策略的必要性。
适用人群与场景
- 成人ICU患者(纳入标准为讨论维生素K缺乏和/或补充的研究)。
研究设计与关键结果
- 共筛选1712篇文章,13篇符合纳入标准。
- 维生素K缺乏与营养不良、吸收受损、抗生素使用、周转增加和遗传因素有关。
- 观察性研究显示ICU患者PIVKA-II水平较高,提示维生素K状态降低。
- 风险因素包括摄入不足、吸收破坏和生理需求增加。
- 补充研究提示维生素K可改善状态但不能完全正常化。
- 维生素K缺乏可能与ICU停留延长、机械通气和死亡率增加相关。
- 遗传多态性和微生物组紊乱也促进缺乏,强调个体化营养策略和进一步研究最佳补充剂量与给药途径的必要性。
证据类型、等级与局限
- 证据类型:范围综述,遵循PRISMA Extension for Scoping Reviews指南,检索PubMed、Embase和Cochrane数据库,无限制。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为解决ICU患者维生素K缺乏对减轻重症相关风险至关重要,但最佳管理策略需进一步研究。
- 作者建议临床医生在重症监护中诊断和管理维生素K缺乏,并为重症患者补充维生素K提供实用策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Vitamin K is essential for numerous physiological processes, including coagulation, bone metabolism, tissue calcification, and antioxidant activity. Deficiency, prevalent in critically ill ICU patients, impacts coagulation and increases the risk of bleeding and other complications. This review aims to elucidate the metabolism of vitamin K in the context of critical illness and identify a potential therapeutic approach.
METHODS: In December 2023, a scoping review was conducted using the PRISMA Extension for Scoping Reviews. Literature was searched in PubMed, Embase, and Cochrane databases without restrictions. Inclusion criteria were studies on adult ICU patients discussing vitamin K deficiency and/or supplementation.
RESULTS: A total of 1712 articles were screened, and 13 met the inclusion criteria. Vitamin K deficiency in ICU patients is linked to malnutrition, impaired absorption, antibiotic use, increased turnover, and genetic factors. Observational studies show higher PIVKA-II levels in ICU patients, indicating reduced vitamin K status. Risk factors include inadequate intake, disrupted absorption, and increased physiological demands. Supplementation studies suggest vitamin K can improve status but not normalize it completely. Vitamin K deficiency may correlate with prolonged ICU stays, mechanical ventilation, and increased mortality. Factors such as genetic polymorphisms and disrupted microbiomes also contribute to deficiency, underscoring the need for individualized nutritional strategies and further research on optimal supplementation dosages and administration routes.
CONCLUSIONS: Addressing vitamin K deficiency in ICU patients is crucial for mitigating risks associated with critical illness, yet optimal management strategies require further investigation.
IMPACT RESEARCH: To the best of our knowledge, this review is the first to address the prevalence and progression of vitamin K deficiency in critically ill patients. It guides clinicians in diagnosing and managing vitamin K deficiency in intensive care and suggests practical strategies for supplementing vitamin K in critically ill patients. This review provides a comprehensive overview of the existing literature, and serves as a valuable resource for clinicians, researchers, and policymakers in critical care medicine.
参考来源
- Paulus MC, Drent M, Kouw IWK, et al. Vitamin K: a potential missing link in critical illness-a scoping review. Crit Care. 2024. PMID: 38956732. doi:10.1186/s13054-024-05001-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。